Christian Bache Billesbølle

Christian Bache Billesbølle

Auto-generated profile, based on publicly available information

Christian Bache Billesbølle

Department of Pharmaceutical Chemistry, University of California, San Francisco, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in Science
Verified
Journal Article
Open access
PDF file
DGDavid E. Gordon
David E. Gordon
JHJoseph Hiatt
Joseph Hiatt
MBMehdi Bouhaddou
Mehdi Bouhaddou
VRVeronica V. Rezelj
Veronica V. Rezelj
SUSvenja Ulferts
Svenja Ulferts
HLHarris A. Lewin
Harris A. Lewin
How lethal coronaviruses engage hosts: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is closely related to the deadly coronaviruses SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV). Considerable efforts are focused on developing treatments, and therapies that work across coronaviruses would be particularly valuable. Shedding light on the host factors hijacked by the viruses, Gordon et al. mapped the interactions between viral and human proteins for SARS-CoV-2, SARS-CoV-1, and MERS-CoV; analyzed the localization of viral proteins in human cells; and used genetic screening to identify host factors that either enhance or inhibit viral infection. For a subset of the interactions essential for the virus life cycle, the authors determined the cryo–electron microscopy structures and mined patient data to understand how targeting host factors may be relevant to clinical outcomes. Science , this issue p. eabe9403

18 December 2020 in Science
Verified
Journal Article
Open access
PDF file
MSMichael Schoof
Michael Schoof
BFBryan Faust
Bryan Faust
RSReuben A. Saunders
Reuben A. Saunders
SSSmriti Sangwan
Smriti Sangwan
VRVeronica Rezelj
Veronica Rezelj
AMAashish Manglik
Aashish Manglik
Nanobodies that neutralize: Monoclonal antibodies that bind to the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) show therapeutic promise but must be produced in mammalian cells and need to be delivered intravenously. By contrast, single-domain antibodies called nanobodies can be produced in bacteria or yeast, and their stability may enable aerosol delivery. Two papers now report nanobodies that bind tightly to spike and efficiently neutralize SARS-CoV-2 in cells. Schoof et al. screened a yeast surface display of synthetic nanobodies and Xiang et al. screened anti-spike nanobodies produced by a llama. Both groups identified highly potent nanobodies that lock the spike protein in an inactive conformation. Multivalent constructs of selected nanobodies achieved even more potent neutralization. Science , this issue p. 1473 , p. 1479

19 August 2020 in Nature
Verified
Journal Article
Closed access
PDF file
CBChristian B. Billesbølle
Christian B. Billesbølle
CACaleigh M. Azumaya
Caleigh M. Azumaya
RKRachael C. Kretsch
Rachael C. Kretsch
APAlexander S. Powers
Alexander S. Powers
SGShane Gonen
Shane Gonen
AMAashish Manglik
Aashish Manglik

15 March 2023 in Nature
Verified
Journal Article
Closed access
PDF file
CBChristian B. Billesbølle
Christian B. Billesbølle
Claire Alice de MarchClaire Alice de March
Claire Alice de March
WVWijnand J. C. van der Velden
Wijnand J. C. van der Velden
NMNing Ma
Ning Ma
JTJeevan Tewari
Jeevan Tewari
AMAashish Manglik
Aashish Manglik

12 May 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
MGMeghna Gupta
Meghna Gupta
CACaleigh M. Azumaya
Caleigh M. Azumaya
MMMichelle Moritz
Michelle Moritz
SPSergei Pourmal
Sergei Pourmal
ADAmy Diallo
Amy Diallo
KVKliment A Verba
Kliment A Verba
The SARS-CoV-2 protein Nsp2 has been implicated in a wide range of viral processes, but its exact functions, and the structural basis of those functions, remain unknown. Here, we report an atomic model for full-length Nsp2 obtained by combining cryo-electron microscopy with deep learning-based structure prediction from AlphaFold2. The resulting structure reveals a highly-conserved zinc ion-binding site, suggesting a role for Nsp2 in RNA binding. Mapping emerging mutations from variants of SARS-CoV-2 on the resulting structure shows potential host-Nsp2 interaction regions. Using structural analysis together with affinity tagged purification mass spectrometry experiments, we identify Nsp2 mutants that are unable to interact with the actin-nucleation-promoting WASH protein complex or with GIGYF2, an inhibitor of translation initiation and modulator of ribosome-associated quality control. Our work suggests a potential role of Nsp2 in linking viral transcription within the viral replication-transcription complexes (RTC) to the translation initiation of the viral message. Collectively, the structure reported here, combined with mutant interaction mapping, provides a foundation for functional studies of this evolutionary conserved coronavirus protein and may assist future drug design.

8 August 2022 in Nature
Verified
Journal Article
Closed access
PDF file
BFBryan Faust
Bryan Faust
CBChristian B. Billesbølle
Christian B. Billesbølle
CSCarl-Mikael Suomivuori
Carl-Mikael Suomivuori
ISIsha Singh
Isha Singh
KZKaihua Zhang
Kaihua Zhang
AMAashish Manglik
Aashish Manglik